Researchers
Leković, Danijela
Results 21-40 of 112
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2024 | Triple a score (AAA: age, absolute neutrophil count and absolute lymphocyte count) and its prognostic utility in patients with overt fibrotic and prefibrotic myelofibrosis![]() | Lucijanic, Marko; Krecak, Ivan; Galusic, Davor; Holik, Hrvoje; Perisa, Vlatka; Moric-Peric, Martina; Zekanovic, Ivan; Budimir, Josipa; Leković, Danijela R. | Other | Mp. category will be shown later |
| 2024 | Thymic hyperplasia as a rare etiology of pure red cell aplasia![]() | Arsenović, Isidora; Leković, Danijela R. | Article | 23M23 |
| 2024 | Does Double Mean Trouble? Coexistence of Myeloproliferative and Lymphoproliferative Neoplasms![]() | Leković, Danijela R. | Article | 21M21 |
| 2024 | ABVD does not fit all advanced-stage classical Hodgkin lymphoma patients: Real-world five-year single-center experience![]() | Vuković, Vojin | Article | 53M53 |
| 2024 | Glycated hemoglobin (HbA1c) and thrombotic risk in polycythemia vera and essential thrombocythemia![]() | Krečak, Ivan; Leković, Danijela R.
Skelin, Marko; Lucijanić, Marko;
| Other | Mp. category will be shown later |
| 2024 | High red cell mass and high plasma volume are independently associated with thrombotic risk in polycythemia vera![]() | Krecak, Ivan; Leković, Danijela R. | Article | 22M22 |
| 2023 | Mutation profile dependence in thrombosis of myeloproliferative neoplasms![]() | Živković, Emilija | Conference Paper | 34 MNO za medicinske nauke (10.07.2024.)M34 |
| 2023 | Age-Adjusted Charlson Comorbidity Index Is a Significant Factor for Predicting Thrombosis Development and Survival in Polycythemia Vera![]() | Leković, Danijela R. | Conference Paper | Mp. category will be shown later |
| 2023 | Easily Applicable Predictive Score for Differential Diagnosis of Prefibrotic Primary Myelofibrosis from Essential Thrombocythemia![]() | Leković, Danijela | Article | 21M21 |
| 2023 | Growth differentiation factor 15, a potential biomarker and a therapeutic target in myeloproliferative neoplasms![]() | Uda, Narasimha Rao; ...; Leković, Danijela R. | Conference Paper | Mp. category will be shown later |
| 2023 | Glycated Hemoglobin (HbA1c) and Thrombotic Risk in Polycythemia Vera and Essential Thrombocythemia![]() | Krečak, Ivan; Leković, Danijela R.
Jakšić, Ozren; Lucijanić, Marko;
| Conference Paper | Mp. category will be shown later |
| 2023 | Comprehensive Next-Generation Sequencing Testing in a Patient with TEMPI Syndrome![]() | Rosado, Flavia Guimaraes Nunes; Leković, Danijela R. | Article | 22M22 |
| 2022 | De novo acute myeloid leukemia harboring concomitant t(8;21)(q22;q22);RUNX1::RUNX1T1 and BCR::ABL1 (p190 minor transcript)![]() | Jaković, Ljubomir | Article | 23M23 |
| 2022 | Correlation between leukocyte-platelet aggregates and thrombosis in myeloproliferative neoplasms![]() | Šefer, Dijana | Article | 22M22 |
| 2022 | Rapid development of lower leg compartment syndrome following firearm injury in a patient with moderate hemophilia B![]() | Bodrožić, Jelena; Leković, Danijela | Other | Mp. category will be shown later |
| 2021 | Characteristics of patients with secondary erythrocytosis in relation to patients with polycythemia vera![]() | Jeremić, Milica; Leković, Danijela | Article | Mp. category will be shown later |
| 2021 | Myelodysplastic/myeloproliferative neoplasm with t(2;11)(P21;Q23)del(5) (Q22;Q33) but without mixed-lineage leukemia (MLL) rearrangement![]() | Čolović, Nataša | Article | 23M23 |
| 2021 | Prediction of optimal cytogenetic responses at 6 and 12 months in patients with chronic myeloid leukemia in chronic phase treated with imatinib![]() | Milošević, Violeta S.; Peruničić-Jovanović, Maja D. | Article | 23M23 |
| 2021 | Several different cytogenetic clones arising during treatment of Philadelphia positive chronic myeloid leukemia with tyrosine kinase inhibitors lead to the progression into Philadelphia negative acute myeloid leukemia![]() | Denčić-Fekete, Marija | Article | 23M23 |
| 2020 | IL6 inhibition of inflammatory S100A8/9 proteins is NF-kappa B mediated in essential thrombocythemia![]() | Diklić, Miloš | Article | 22M22 |

